Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
American Heart Association
AHA publishes statement on infective endocarditis
August 10th, 2005
The American Heart Association has published a statement for healthcare professionals on the diagnosis, antimicrobial therapy, and management of complications in infective endocarditis. According to their report, "Despite advances in medical, surgical, and critical care interventions, infective endocarditis remains a disease that is associated with considerable morbidity and mortality. The continuing evolution of antimicrobial resistance among common pathogens that cause infective endocarditis creates additional therapeutic issues for physicians to manage in this potentially life-threatening illness." The statement authors wrote, "This work...
Source: Biotech Week (2005-08-10)
|
